PostersISBT2006PostersTOPIC 02.1TOPIC 02.1P-226 COMPARATIVE STUDY OF TUBE AND GEL TECHNIQUES FORCOMPATIBILITY TESTING AND ANTIBODY IDENTIFICATIONR.N. Makroo, S.G. Gautam (Apollo Hospitals, Delhi, India)P-234 APPLICATION OF FY GENOTYPING TO DETERMINE BLOODGROUP-SPECIFIC CHIMERISM AFTER ALLOGENEIC PERIPHERALBLOOD STEM CELL TRANSPLANTATIONP-227 RHD GENE MOLECULAR VARIANTS IN THE WESTERN PART OFFRANCE : IDENTIFICATION OF 13 NEW ALLELESC. le Marechal, C. Guerry, C. Benech, L. Burlot, F. Cordellier, M. Delamaire, C. Ferec(French <strong>Blood</strong> Center, Brest, France)M.A. Mota, A.A. Ciferri, R.A.A. Pereira, A.M. Sakashita, J.M. Kutner, L.M. Castilho(IEP/Hospital Albert Einstein, São Paulo, Brazil)P-235 IDENTIFICATION AND MOLECULAR CHARACTERIZATION OF HY ANDJOA NEGATIVE BLOOD DONORS IN SOUTHERN USAP-228 GENOTYPING OF DUFFY, KIDD, MNS BLOOD GROUPS :THE EFS PYRENEES MEDITERRANEE EXPERIENCEC. Maugard, R. Aznar, N. Chikh, C. Segarra, O. Bouix, J. Coste (EFS Pyrénées Mediterranée,Montpellier, France)M. Moulds, W. Long, Q. Chen, M. Stone, D. Tulley, E. Lowery, A. Steinmetz, J. Moulds(LifeShare <strong>Blood</strong> Centers, Shreveport, United States of America)P-236 ANTIBODY PREVALENCE IN A HETEROGENEOUS POPULATION OFPREGNANT WOMEN AND NEONATES96P-229 ANTI-JK3 ALLOANTIBODIES IN THE PATIENT WITH JK NULLPHENOTYPE AND JKA/JKA GENOTYPEE. Brojer, B. Michalewska, A. Kucmierz, M. Pelc-Klopotowska, A. Orzinska, H. Lopienska(Institute of Haematology and <strong>Blood</strong> <strong>Transfusion</strong>, Warsaw, Poland)P-230 EVALUATION OF THE DIAGAST ERYTHROCYTES MAGNETIZEDTECHNOLOGYL.A. Mohabir, C. Womersley, Y. Barbreau, A.S. Degryse, J.M. Pelosin (Welsh <strong>Blood</strong> Service,Pontyclun, United Kingdom)P-231 UNUSUAL ANTIBODY SPECIFICITY IN AN AFRICAN AMERICANPATIENT WITH U-VARIANT RED BLOOD CELLSC. Lomas-Francis, K. Hue-Roye, A. Fuchisawa, S.Y. Choo, C. m.d. Whitsett (New York <strong>Blood</strong>Center, New York, United States of America)P-232 EVALUATION OF A NEW TECHNOLOGY FOR BLOOD GROUPING ANDPHENOTYPINGM.A. Mota, M.G. Aravechia, V.L. Wakim, A.M. Sakashita, J.M. Kutner, L.M. Castilho(IEP/Hospital Albert Einstein, São Paulo, Brazil)P-233 POST-TRANSFUSION HYPERHEMOLYSIS AFTER HEMOLYTIC TRANS-FUSION REACTION IN A PATIENT WITH SEVERE ANEMIA: CASE REPORTM.A. Mota, A.M. Sakashita, N. Hamerschlak, J.M. Kutner, L.M. Castilho (IEP/Hospital AlbertEinstein, São Paulo, Brazil)S. Mudahi-Orenstein, N. Lev, Y. Dakosta, O. Zelig, N. Manny (Hadassah Hebrew UniversityMedical Center, Jerusalem, Israel)P-237 DETECTION OF WEAK D TYPE 1, 2 AND 3 WITHIN WEAK D/C+ ANDWEAK D/E+ RECIPIENTS IN DAILY PRACTICE : SEROLOGY, MOLECULARBIOLOGY OR BOTH ?F. Noizat-Pirenne, M. Verdier, A. Lejealle, A. Mercadier, A. Fialaire-Legendre, C. Tournamille,P. Bonin, P. Bierling, H. Ansart-Pirenne (Etablissement Français du Sang, Créteil, France)P-238 A MODIFIED TREATMENT PROCESS FOR PREPARATION OF S-303RBC FOR PATHOGEN INACTIVATION SUBSTANTIALLY REDUCES THEPOTENTIAL FOR CROSS-REACTIVITYA. North, G. Garratty, M.A. Schott, P. Arndt, G. Castro, A. Erickson, P. Mintz, L. Corash (CerusCorporation, Concord, Ca, United States of America)P-239 THREE NEW FUT1 ALLELES ENCODE DEFECTIVE FUCOSYLTRANS-FERASES IDENTIFIED FROM PARA-BOMBAY PHENOTYPE INDIVIDUALSK. Ogasawara, H. Tsuneyama, M. Uchikawa, S. Itou, K. Tadokoro, M. Satake, K. Nakajima(Red Cross Central <strong>Blood</strong> Institute, Tokyo, Japan)P-240 A CASE OF SEVERE RH D ALLOIMMUNIZATION TREATED BYINTENSIVE PLASMA EXCHANGE AND HIGH-DOSE INTRAVENOUSIMMUNOGLOBULINP.M. Palfi, L. Matthiesen, J.O. Hilden, A. Selbing, G. Berlin (University Hospital, Linköping, Sweden)97INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT
PostersISBT2006PostersTOPIC 02.1TOPIC 02.1P-241 MCLEOD PHENOTYPE - PHENOTYPE AND GENOTYPE IN A CASEOF MCLEOD SYNDROME WITH SEVERE NEUROLOGICAL SYMPTOMESP-249 PROJECT IN DEVELOPING PANEL CELLS FOR ANTIBODYSCREENING AND IDENTIFICATION IN INDONESIAM. Písacka, L. Tilley, M. Kralova, J. Klempir, J. Roth (Instituteof Hematology and <strong>Blood</strong>R.S.E.G. Sjavitri Evi Gantini, T.H. Titik Herniwati, R.L. Crookes, M.R. Muhammad Rizal<strong>Transfusion</strong>, Prague, Czech Republic)(CBTS Indonesian Red Cross, Jakarta, Indonesia)P-242 MEDIATORS OF THE SELECTIVE CLEARANCE OF SENESCENTERYTHROCYTESP-250 A REVIEW OF THE CLINICAL SIGNIFICANCE OF ANTI-RH19 ANDANTI-RH34 ANTIBODIES DETECTED IN SOUTH AFRICAN PATIENTSA. Racca, C. Biondi, M.A. Ensinck, S. García Borrás, L. Racca, C. Cotorruelo (Facultad deE.A. Smart, P. Fogg, S. Nadesan, I. Joseph (South African National <strong>Blood</strong> Service, EC,Bioquímica, Rosario, Argentina)Durban, South Africa)P-243 RHMOD PHENOTYPE CAUSED BY DOUBLE HETEROZYGOSITY FORTWO NEW ALLELES OF THE RHAG GENEP-251 USING NON-TRADITIONAL QUALITY TOOLS TO EVALUATEAUTOMATION FOR PRETRANSFUSION TESTINGA. Scharberg, H. Tsuneyama, K. Ogasawara, M. Uchikawa, H.H. Keller, K. Panter, J. Senne,F. South, T. Casina, W. Malomgre (Ortho-Clinical Diagnostics, Scottsdale, United States of America)98S. Penz, E. Richter, P. Bugert (DRK-BSD Baden-Wuerttemberg-Hessen, Baden-Baden, Germany)P-244 OUR EXPIRIENCES IN TYPING AND SCREENING RED CELLALO-ANTIBODIES IN SERA OF PATIENTS WHO ARE TESTED BY THECOLUMN AGGLUTINATION TECHNOLOGY ANTI-HUMAN GLOBULIN TESTB. Stankovic, M. Trkuljic (Institute of Transfusiology, Belgrade, Yugoslavia)P-245 B-CELL MEMORY AGAINST RHD ANTIGEN IN HYPERIMMUNIZEDDONORS IS MAINLY PRESENT IN A CD27 NEGATIVE IGM POSITIVEB-CELL SUBSETC.E. van der Schoot, C.E. van der Schoot, L.J. Gruneberg, O.H.M. Verhagen, G. Vidarsson,S.E. Dohmen (Sanquin Research, Amsterdam, Netherlands)P-252 THE FIRST TWO CASE REPORTS OF ANTI-JAHK (RH53)IN PREGNANT WOMENA. Scharberg, K. Panter, J. Senne, S. Penz, E. Richter, G. Bojarsky, M. Leuteritz (DRK-BSDBaden-Wuerttemberg-Hessen, Baden-Baden, Germany)P-253 MOLECULAR BASIS FOR A NOVEL LOW-FREQUENCY ANTIGEN INTHE MNS BLOOD GROUP SYSTEM, TDM. Uchikawa, H. Tsuneyama, K. Ogasawara, Y Suzuki, R. Yabe, T Enomoto, M Satake,K Nakajima (Tokyo <strong>Blood</strong> Center, Tokyo, Japan)P-254 THE EVALUATION OF GENOTYPES OF LEWIS BLOOD GROUP INKOREAN USING DIRECT SEQUENCING AND RFLP.99P-246 O BLOOD GROUP, WHERE ART THOU?A. Seltsam, C. Figueiredo, C. Das Gupta, O. Bock, R. Blasczyk (Hannover Medical School,Hannover, Germany)P-247 THE INCIDENCE OF DCE RH PHENOTYPE IN NAKASERO BLOODBANK DONORSP. Senyonga (Uganda <strong>Blood</strong> <strong>Transfusion</strong> Service, Kampala, Uganda)P-248 RBC ALLOANTIBODIES FREQUENCY IN PREGNANT WOMENL. Suput-Tomas, M. Paunovic, B. Jankovic-Orescanin, G. Buric (Clinical-Hospital Center"Zvezdara", Belgrade, Serbia and Montenegro)I.B. Suh, S.W. Ryu, J.S. Kim, C.S. Lim, C.K. Lee, Y. Cho, Y.K. Kim, K.N. Lee(Kangwon Natl. Univ, Medical Science Inst, Chunchun, South-Korea)P-255 IDENTIFICATION OF A NOVEL A1V-O1V HYBRID ALLELE WITH G829AMUTATION IN A CHIMERIC INDIVIDUAL OF AELBEL PHENOTYPEC.F. Sun, D.P. Chen, W.T. Wang, J.P. Liu (Chang Gung Memorial Hospital, Tao-yuan, Taiwan)P-256 EVALUATION OF MICROPLATE SYSTEM FOR ABOAND RH(D) BLOOD GROUPINGJ.S. Shukla, R. Chaudhary, D. Khetan, A. Sonker (SG Postgraduate Institute of Medical Sci,Lucknow, India)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT
- Page 24 and 25: XXIX th International Congressof th
- Page 26 and 27: ISBT2006WORDS OF WELCOME5It is with
- Page 28 and 29: ISBT20068ORGANISATION - COMMITTEESO
- Page 30 and 31: Programme per DayISBT2006Programme
- Page 32 and 33: ISBT2006Programme per DayTHURSDAY,
- Page 34 and 35: Sunday, 3 SeptemberISBT2006Sunday,
- Page 36 and 37: Sunday, 3 SeptemberISBT2006Monday,
- Page 38 and 39: Monday, 4 SeptemberISBT2006Monday,
- Page 40 and 41: Monday, 4 SeptemberISBT2006Monday,
- Page 42 and 43: Monday, 4 SeptemberISBT2006Monday,
- Page 44 and 45: Monday, 4 SeptemberISBT2006Tuesday,
- Page 46 and 47: Tuesday, September 5ISBT2006Wednesd
- Page 48 and 49: Wednesday, 6 SeptemberISBT2006Wedne
- Page 50 and 51: Wednesday, 6 SeptemberISBT2006Wedne
- Page 52 and 53: Wednesday, 6 SeptemberISBT2006Wedne
- Page 54 and 55: Wednesday, 6 SeptemberISBT2006Thurs
- Page 56 and 57: Thursday, 7 SeptemberISBT2006Thursd
- Page 58 and 59: PostersISBT2006PostersTOPIC 01.1The
- Page 60 and 61: PostersISBT2006PostersTOPIC 01.2TOP
- Page 62 and 63: PostersISBT2006PostersTOPIC 01.2TOP
- Page 64 and 65: PostersISBT2006PostersTOPIC 01.5The
- Page 66 and 67: PostersISBT2006PostersTOPIC 01.6TOP
- Page 68 and 69: PostersISBT2006PostersTOPIC 01.8The
- Page 70 and 71: PostersISBT2006PostersTOPIC 02.1TOP
- Page 74 and 75: PostersISBT2006PostersTOPIC 02.1TOP
- Page 76 and 77: PostersISBT2006PostersTOPIC 02.2TOP
- Page 78 and 79: PostersISBT2006PostersTOPIC 02.4TOP
- Page 80 and 81: PostersISBT2006PostersTOPIC 03.2The
- Page 82 and 83: PostersISBT2006PostersTOPIC 04.3The
- Page 84 and 85: PostersISBT2006PostersTOPIC 05.2The
- Page 86 and 87: PostersISBT2006PostersTOPIC 05.2TOP
- Page 88 and 89: PostersISBT2006PostersTOPIC 07.2The
- Page 90 and 91: PostersISBT2006PostersTOPIC 08.1-3T
- Page 92 and 93: PostersISBT2006PostersTOPIC 09.2TOP
- Page 94 and 95: PostersISBT2006PostersTOPIC 10.1TOP
- Page 96 and 97: PostersISBT2006PostersTOPIC 11.1The
- Page 98 and 99: PostersISBT2006PostersTOPIC 11.4The
- Page 100 and 101: PostersISBT2006PostersTOPIC 13.0TOP
- Page 102 and 103: PostersISBT2006PostersTOPIC 15.0TOP
- Page 104 and 105: ISBT Business MeetingsISBT2006Key I
- Page 106 and 107: Key InformationISBT2006Key Informat
- Page 108 and 109: Scientific InformationISBT2006Scien
- Page 110 and 111: Registration InformationISBT2006Soc
- Page 112 and 113: ISBT2006FLOORPLANGROUND FLOORFLOORP
- Page 114 and 115: ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 116 and 117: ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 118 and 119: ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 120 and 121: ISBT2006LIST OF EXHIBITORSin terms
- Page 122 and 123:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 124 and 125:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 126 and 127:
ISBT2006LIST OF EXHIBITORS59 Cape C
- Page 128 and 129:
ISBT2006MAP OF CAPE TOWNSPEAKERS IN
- Page 130 and 131:
International Society ofBlood Trans
- Page 132:
ISBT2006NOTES216INTERNATIONAL SOCIE